Synopsis
0
USDMF
0
CEP/COS
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ANALYTICAL
ABOUT THIS PAGE
15
PharmaCompass offers a list of Prednisolone Valerate Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Prednisolone Valerate Acetate manufacturer or Prednisolone Valerate Acetate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Prednisolone Valerate Acetate manufacturer or Prednisolone Valerate Acetate supplier.
PharmaCompass also assists you with knowing the Prednisolone Valerate Acetate API Price utilized in the formulation of products. Prednisolone Valerate Acetate API Price is not always fixed or binding as the Prednisolone Valerate Acetate Price is obtained through a variety of data sources. The Prednisolone Valerate Acetate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Lidomex manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lidomex, including repackagers and relabelers. The FDA regulates Lidomex manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lidomex API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Lidomex manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Lidomex supplier is an individual or a company that provides Lidomex active pharmaceutical ingredient (API) or Lidomex finished formulations upon request. The Lidomex suppliers may include Lidomex API manufacturers, exporters, distributors and traders.
click here to find a list of Lidomex suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Lidomex Drug Master File in Japan (Lidomex JDMF) empowers Lidomex API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Lidomex JDMF during the approval evaluation for pharmaceutical products. At the time of Lidomex JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Lidomex suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Lidomex Drug Master File in Korea (Lidomex KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Lidomex. The MFDS reviews the Lidomex KDMF as part of the drug registration process and uses the information provided in the Lidomex KDMF to evaluate the safety and efficacy of the drug.
After submitting a Lidomex KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Lidomex API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Lidomex suppliers with KDMF on PharmaCompass.
A Lidomex written confirmation (Lidomex WC) is an official document issued by a regulatory agency to a Lidomex manufacturer, verifying that the manufacturing facility of a Lidomex active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Lidomex APIs or Lidomex finished pharmaceutical products to another nation, regulatory agencies frequently require a Lidomex WC (written confirmation) as part of the regulatory process.
click here to find a list of Lidomex suppliers with Written Confirmation (WC) on PharmaCompass.
Lidomex Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lidomex GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lidomex GMP manufacturer or Lidomex GMP API supplier for your needs.
A Lidomex CoA (Certificate of Analysis) is a formal document that attests to Lidomex's compliance with Lidomex specifications and serves as a tool for batch-level quality control.
Lidomex CoA mostly includes findings from lab analyses of a specific batch. For each Lidomex CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lidomex may be tested according to a variety of international standards, such as European Pharmacopoeia (Lidomex EP), Lidomex JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lidomex USP).
